blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1115877

EP1115877 - POLYNUCLEOTIDE CONSTRUCTS AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.11.2009
Database last updated on 03.10.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY		published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
Oxford Biomedica (UK) Limited
Medawar Centre, Robert Robinson Avenue, The Oxford Science Park
Oxford OX4 4GA / GB
[N/P]
Former [2009/03]For all designated states
Oxford Biomedica (UK) Limited
Medawar Centre, Robert Robinson Avenue, The Oxford Science Park
Oxford 0X4 4GA / GB
Former [2001/29]For all designated states
Oxford Biomedica (UK) Limited
Medawar Centre, Robert Robinson Avenue, The Oxford Science Park
Oxford 0X4 4GA / GB
Inventor(s)01 / BINLEY, Katie Mary
17 Demesne Furze, Headington
Oxford OX3 7XF / GB
02 / NAYLOR, Stuart
64 Woodside Road
Amersham, Bucks HP6 6AN / GB
 [2001/29]
Representative(s)Harding, Charles Thomas, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2009/26]Harding, Charles Thomas, et al
D Young & Co 120 Holborn London
EC1N 2DY / GB
Former [2008/24]Harding, Charles Thomas, et al
D Young & Co 120 Holborn
London EC1N 2DY / GB
Former [2001/29]Maschio, Antonio
D Young & Co, 21 New Fetter Lane
London EC4A 1DA / GB
Application number, filing date99949142.622.09.1999
[2001/29]
WO1999GB03181
Priority number, dateWO1998GB0288523.09.1998         Original published format: PCT/GB98/02885
GB1999000190628.01.1999         Original published format: GB 9901906
GB1999000353816.02.1999         Original published format: GB 9903538
[2001/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0017371
Date:30.03.2000
Language:EN
[2000/13]
Type: A1 Application with search report 
No.:EP1115877
Date:18.07.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 30.03.2000 takes the place of the publication of the European patent application.
[2001/29]
Type: B1 Patent specification 
No.:EP1115877
Date:14.01.2009
Language:EN
[2009/03]
Search report(s)International search report - published on:EP30.03.2000
ClassificationIPC:C12N15/63, C12N15/86, C12N7/01, C12N5/10, C07K14/47, A61K48/00
[2001/29]
CPC:
C12N15/63 (EP); C12N15/113 (KR); A61K48/00 (EP);
A61P1/00 (EP); A61P1/02 (EP); A61P1/04 (EP);
A61P1/16 (EP); A61P11/06 (EP); A61P13/00 (EP);
A61P15/00 (EP); A61P17/00 (EP); A61P19/02 (EP);
A61P21/00 (EP); A61P25/00 (EP); A61P25/16 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P27/16 (EP);
A61P29/00 (EP); A61P35/00 (EP); A61P37/02 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P5/14 (EP);
A61P7/00 (EP); A61P9/08 (EP); A61P9/10 (EP);
C07K14/4702 (EP); C12N15/86 (EP); C12N2710/10343 (EP);
C12N2740/13043 (EP); C12N2830/00 (EP); C12N2830/002 (EP);
C12N2830/008 (EP); C12N2830/15 (EP); C12N2830/42 (EP);
C12N2830/48 (EP); C12N2830/50 (EP); C12N2840/206 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/29]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:POLYNUCLEOTIDKONSTRUKTE UND IHRE VERWENDUNGEN[2001/29]
English:POLYNUCLEOTIDE CONSTRUCTS AND USES THEREOF[2001/29]
French:PRODUITS DE RECOMBINAISON POLYNUCLEOTIDIQUES ET LEURS UTILISATIONS[2001/29]
Entry into regional phase17.04.2001National basic fee paid 
17.04.2001Designation fee(s) paid 
17.04.2001Examination fee paid 
Examination procedure28.02.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
18.04.2001Examination requested  [2001/29]
22.12.2003Despatch of a communication from the examining division (Time limit: M04)
29.04.2004Reply to a communication from the examining division
11.01.2005Despatch of a communication from the examining division (Time limit: M06)
21.07.2005Reply to a communication from the examining division
15.11.2005Despatch of a communication from the examining division (Time limit: M06)
15.05.2006Reply to a communication from the examining division
12.01.2007Despatch of a communication from the examining division (Time limit: M06)
24.05.2007Reply to a communication from the examining division
15.10.2007Despatch of a communication from the examining division (Time limit: M01)
29.10.2007Reply to a communication from the examining division
25.07.2008Communication of intention to grant the patent
14.11.2008Fee for grant paid
14.11.2008Fee for publishing/printing paid
Opposition(s)15.10.2009No opposition filed within time limit [2009/52]
Fees paidRenewal fee
12.09.2001Renewal fee patent year 03
06.09.2002Renewal fee patent year 04
09.09.2003Renewal fee patent year 05
07.09.2004Renewal fee patent year 06
14.09.2005Renewal fee patent year 07
14.09.2006Renewal fee patent year 08
14.09.2007Renewal fee patent year 09
26.03.2008Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT14.01.2009
CY14.01.2009
DK14.01.2009
FI14.01.2009
IT14.01.2009
NL14.01.2009
SE14.04.2009
GR15.04.2009
ES25.04.2009
PT15.06.2009
GB22.09.2009
IE22.09.2009
LU22.09.2009
BE30.09.2009
CH30.09.2009
FR30.09.2009
LI30.09.2009
MC30.09.2009
[2011/45]
Former [2011/25]AT14.01.2009
DK14.01.2009
FI14.01.2009
IT14.01.2009
NL14.01.2009
SE14.04.2009
GR15.04.2009
ES25.04.2009
PT15.06.2009
GB22.09.2009
IE22.09.2009
LU22.09.2009
BE30.09.2009
CH30.09.2009
FR30.09.2009
LI30.09.2009
MC30.09.2009
Former [2010/44]AT14.01.2009
DK14.01.2009
FI14.01.2009
NL14.01.2009
SE14.04.2009
ES25.04.2009
PT15.06.2009
IE22.09.2009
BE30.09.2009
FR30.09.2009
MC30.09.2009
Former [2010/28]AT14.01.2009
DK14.01.2009
FI14.01.2009
NL14.01.2009
SE14.04.2009
ES25.04.2009
PT15.06.2009
MC30.09.2009
Former [2010/06]AT14.01.2009
DK14.01.2009
FI14.01.2009
NL14.01.2009
SE14.04.2009
ES25.04.2009
PT15.06.2009
Former [2009/30]NL14.01.2009
Cited inInternational search[DA]WO9521927  (ISIS INNOVATION [GB], et al) [DA] * the whole document *;
 [A]WO9620276  (STANFORD RES INST INT [US], et al) [A] * the whole document *;
 [DA]WO9815294  (UNIV SHEFFIELD [GB], et al) [DA] * the whole document *;
 [A]WO9819695  (MODEX THERAPEUTIQUES [CH]) [A] * the whole document *;
 [A]WO9831701  (UNIV TEXAS [US]) [A] * the whole document *;
 [PX]WO9915684  (OXFORD BIOMEDICA LTD [GB], et al) [PX] 5,8,9,12,15-22,25-31 * the whole document *;
 [PX]  - K. BOAST ET AL., "Characterization of physiologically regulated vectors for the treatment of ischemic disease", HUMAN GENE THERAPY, MARY ANN LIEBERT, INC. PUBLISHERS, NEW YORK, US, (19990901), vol. 10, no. 13, pages 2197 - 2208, XP000876772 [PX] 5,8,9,12,15-22,25-31 * the whole document *

DOI:   http://dx.doi.org/10.1089/10430349950017185
 [A]  - G U DACHS ET AL, "Targeting gene expression to hypoxic tumor cells", NATURE MEDICINE,US,NATURE PUBLISHING, CO, (19970501), vol. 3, no. 5, ISSN 1078-8956, pages 515 - 520, XP002096343 [A] * the whole document *

DOI:   http://dx.doi.org/10.1038/nm0597-515
 [DA]  - K.M. LONERGAN ET AL., "Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2", MOL. CELL. BIOL., ASM WASHINGTON, DC,US, (199802), vol. 18, no. 2, pages 732 - 741, XP002130567 [DA] * the whole document *
 [A]  - K. BINLEY ET AL., "An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer", GENE THERAPY, MACMILLAN PRESS, UK, (199610), vol. 6, no. 10, pages 1721 - 1727, XP000876756 [A] * the whole document *

DOI:   http://dx.doi.org/10.1038/sj.gt.3301001
 [A]  - MADAN A ET AL, "A 24-BASE-PAIR SEQUENCE 3' TO THE HUMAN ERYTHROPOIETIN GENE CONTAINS A HYPOXIA-RESPONSIVE TRANCRIPTIONAL ENHANCER", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,US,NATIONAL ACADEMY OF SCIENCE. WASHINGTON, (19930501), vol. 90, no. 9, ISSN 0027-8424, pages 3928 - 3932, XP000561802 [A] * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.90.9.3928
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.